Gain-of-function cardiomyopathic mutations in RBM20 rewire splicing regulation and re-distribute ribonucleoprotein granules within processing bodies.
Gain-of-function cardiomyopathic mutations in RBM20 rewire splicing regulation and re-distribute ribonucleoprotein granules within processing bodies.
复制标题
DOI:
10.1038/s41467-021-26623-y
复制
发表时间:
2021-11-03
影响因子:
16.6
通讯作者:
Salomonis N
中科院分区:
文献类型:
--
作者:
Fenix AM;Miyaoka Y;Bertero A;Blue SM;Spindler MJ;Tan KKB;Perez-Bermejo JA;Chan AH;Mayerl SJ;Nguyen TD;Russell CR;Lizarraga PP;Truong A;So PL;Kulkarni A;Chetal K;Sathe S;Sniadecki NJ;Yeo GW;Murry CE;Conklin BR;Salomonis N
Mutations in the cardiac splicing factor RBM20 lead to malignant dilated cardiomyopathy (DCM). To understand the mechanism of RBM20-associated DCM, we engineered isogenic iPSCs with DCM-associated missense mutations in RBM20 as well as RBM20 knockout (KO) iPSCs. iPSC-derived engineered heart tissues made from these cell lines recapitulate contractile dysfunction of RBM20-associated DCM and reveal greater dysfunction with missense mutations than KO. Analysis of RBM20 RNA binding by eCLIP reveals a gain-of-function preference of mutant RBM20 for 3′ UTR sequences that are shared with amyotrophic lateral sclerosis (ALS) and processing-body associated RNA binding proteins (FUS, DDX6). Deep RNA sequencing reveals that the RBM20 R636S mutant has unique gene, splicing, polyadenylation and circular RNA defects that differ from RBM20 KO. Super-resolution microscopy verifies that mutant RBM20 maintains very limited nuclear localization potential; rather, the mutant protein associates with cytoplasmic processing bodies (DDX6) under basal conditions, and with stress granules (G3BP1) following acute stress. Taken together, our results highlight a pathogenic mechanism in cardiac disease through splicing-dependent and -independent pathways. Mutations in the splicing factor RBM20 cause aggressive Dilated Cardiomyopathy. Here the authors generated RBM20 R636S mutants and knockout in human iPSC-derived cardiomyocytes. Mutant RBM20 showed different target RNA binding, altered splicing and localization to cytoplasmic processing bodies.
登录
查看更多内容
影响因子:
12.3
作者:
Carpenter AE;Jones TR;Lamprecht MR;Clarke C;Kang IH;Friman O;Guertin DA;Chang JH;Lindquist RA;Moffat J;Golland P;Sabatini DM
通讯作者:
Sabatini DM
影响因子:
4.6
作者:
Ihara K;Sasano T;Hiraoka Y;Togo-Ohno M;Soejima Y;Sawabe M;Tsuchiya M;Ogawa H;Furukawa T;Kuroyanagi H
通讯作者:
Kuroyanagi H
影响因子:
20.1
作者:
Campostrini G;Windt LM;van Meer BJ;Bellin M;Mummery CL
通讯作者:
Mummery CL
影响因子:
64.8
作者:
Hondele, Maria;Sachdev, Ruchika;Weis, Karsten
通讯作者:
Weis, Karsten
影响因子:
10.5
作者:
Conlon EG;Manley JL
通讯作者:
Manley JL